直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.

Synthon Pharmaceuticals, Inc.

Eli Lilly and Co.; ICOS

Represented Eli Lilly and ICOS in Hatch-Waxman patent litigation concerning ANDA for generic version of drug Adcirca®.

Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.; ICOS , 5:10-cv-00150, E.D.N.C., Judge Dever

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Eli Lilly and Co. v. Apotex Inc.

Eli Lilly and Company

Sun Pharmaceutical Inds. v. Eli Lilly and Co. 

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Sicor Pharmaceuticals, Inc.

Eli Lilly and Company

Certain Gemcitabine and Products Containing Same

Eli Lilly and Company

Alzheimer's Institute of America, Inc. v. Eli Lilly and Company

Eli Lilly and Company

GlaxoSmithKline v. Synthon Pharmaceuticals, Inc. 

GlaxoSmithKline

Hospira, Inc. v. Eli Lilly and Co.

Eli Lilly and Co.

Eli Lilly & Co. v. Wockhardt Ltd.

Eli Lilly and Company

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP